Multicenter, randomized phase II trial of physical activity (PA), metformin (Met), or the combination on metabolic biomarkers in stage I-III colorectal (CRC) and breast cancer (BC) survivors Meeting Abstract


Authors: Meyerhardt, J. A.; Irwin, M. L.; Jones, L.; Zhang, S.; Campbell, N.; Brown, J. C.; Pollak, M. N.; Sorrentino, A.; Cartmel, B.; Harrigan, M.; West, M.; Tolaney, S. M.; Yung, R. L.; Winer, E. P.; Ng, K.; Abrams, T. A.; Fuchs, C. S.; Sanft, T. B.; Douglas, P.; Ligibel, J. A.
Abstract Title: Multicenter, randomized phase II trial of physical activity (PA), metformin (Met), or the combination on metabolic biomarkers in stage I-III colorectal (CRC) and breast cancer (BC) survivors
Meeting Title: 53rd Annual Meeting of the American Society of Clinical Oncology (ASCO)
Journal Title: Journal of Clinical Oncology
Volume: 35
Issue: 15 Suppl.
Meeting Dates: 2017 Jun 2-6
Meeting Location: Chicago, IL
ISSN: 0732-183X
Publisher: American Society of Clinical Oncology  
Date Published: 2017-05-20
Start Page: 515s
Language: English
ACCESSION: WOS:000411932204185
DOI: 10.1200/JCO.2017.35.15_suppl.10059
PROVIDER: wos
Notes: Meeting Abstract: 10059 -- Source: Wos
Altmetric
Citation Impact
BMJ Impact Analytics
MSK Authors
  1. Lee Winston Jones
    179 Jones